Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Sees Large Increase in Short Interest

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) saw a significant growth in short interest in July. As of July 31st, there was short interest totaling 467,461 shares, a growth of 161.0% from the July 15th total of 179,105 shares. Based on an average daily volume of 2,318,553 shares, the short-interest ratio is currently 0.2 days. Currently, 4.2% of the company’s stock are sold short.

Hong Kong Pharma Digital Technology Price Performance

Shares of Hong Kong Pharma Digital Technology stock opened at $0.42 on Friday. The company’s 50-day moving average price is $0.41 and its 200-day moving average price is $0.57. Hong Kong Pharma Digital Technology has a 12-month low of $0.31 and a 12-month high of $2.58.

Hong Kong Pharma Digital Technology (NASDAQ:HKPD) last announced its earnings results on Friday, August 7th. The company reported ($0.04) earnings per share (EPS) for the quarter. The company had revenue of $3.15 million for the quarter.

Institutional Trading of Hong Kong Pharma Digital Technology

A hedge fund recently bought a new stake in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. acquired a new position in shares of Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned approximately 0.39% of Hong Kong Pharma Digital Technology at the end of the most recent reporting period.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Hong Kong Pharma Digital Technology in a report on Wednesday, July 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Hong Kong Pharma Digital Technology Company Profile

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.